These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 25873348)
61. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Angus WG; Larsen MC; Jefcoate CR Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772 [TBL] [Abstract][Full Text] [Related]
62. Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3'-diindolylmethane in breast cancer cells. Degner SC; Papoutsis AJ; Selmin O; Romagnolo DF J Nutr; 2009 Jan; 139(1):26-32. PubMed ID: 19056653 [TBL] [Abstract][Full Text] [Related]
63. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells. Wormke M; Castro-Rivera E; Chen I; Safe S J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009 [TBL] [Abstract][Full Text] [Related]
65. Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. Miao H; Wang YN; Yu XY; Zou L; Guo Y; Su W; Liu F; Cao G; Zhao YY Br J Pharmacol; 2024 Jan; 181(1):162-179. PubMed ID: 37594378 [TBL] [Abstract][Full Text] [Related]
66. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer. Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661 [TBL] [Abstract][Full Text] [Related]
67. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Henry EC; Bemis JC; Henry O; Kende AS; Gasiewicz TA Arch Biochem Biophys; 2006 Jun; 450(1):67-77. PubMed ID: 16545771 [TBL] [Abstract][Full Text] [Related]
68. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). Guo M; Joiakim A; Reiners JJ Biochem Pharmacol; 2000 Sep; 60(5):635-42. PubMed ID: 10927021 [TBL] [Abstract][Full Text] [Related]
69. Genome-wide RNAi high-throughput screen identifies proteins necessary for the AHR-dependent induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Solaimani P; Damoiseaux R; Hankinson O Toxicol Sci; 2013 Nov; 136(1):107-19. PubMed ID: 23997114 [TBL] [Abstract][Full Text] [Related]
70. IL-1 and TNF-α regulation of aryl hydrocarbon receptor (AhR) expression in HSY human salivary cells. Drozdzik A; Dziedziejko V; Kurzawski M Arch Oral Biol; 2014 Apr; 59(4):434-9. PubMed ID: 24565903 [TBL] [Abstract][Full Text] [Related]
72. Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway. Monteiro P; Gilot D; Le Ferrec E; Rauch C; Lagadic-Gossmann D; Fardel O Mol Pharmacol; 2008 Mar; 73(3):769-77. PubMed ID: 18089838 [TBL] [Abstract][Full Text] [Related]
73. Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR). Vrzal R; Marcalíková A; Krasulová K; Zemánková L; Dvořák Z Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958638 [TBL] [Abstract][Full Text] [Related]
74. Ligand binding and functional selectivity of L-tryptophan metabolites at the mouse aryl hydrocarbon receptor (mAhR). Nuti R; Gargaro M; Matino D; Dolciami D; Grohmann U; Puccetti P; Fallarino F; Macchiarulo A J Chem Inf Model; 2014 Dec; 54(12):3373-83. PubMed ID: 25402742 [TBL] [Abstract][Full Text] [Related]
75. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Döhr O; Vogel C; Abel J Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066 [TBL] [Abstract][Full Text] [Related]
76. Differentiation of pluripotent C3H10T1/2 cells rapidly elevates CYP1B1 through a novel process that overcomes a loss of Ah Receptor. Cho YC; Zheng W; Yamamoto M; Liu X; Hanlon PR; Jefcoate CR Arch Biochem Biophys; 2005 Jul; 439(2):139-53. PubMed ID: 15967407 [TBL] [Abstract][Full Text] [Related]
77. Time-dependent transcriptomic and biochemical responses of 6-formylindolo[3,2-b]carbazole (FICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are explained by AHR activation time. Farmahin R; Crump D; O'Brien JM; Jones SP; Kennedy SW Biochem Pharmacol; 2016 Sep; 115():134-43. PubMed ID: 27301797 [TBL] [Abstract][Full Text] [Related]
78. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Zhang S; Qin C; Safe SH Environ Health Perspect; 2003 Dec; 111(16):1877-82. PubMed ID: 14644660 [TBL] [Abstract][Full Text] [Related]
79. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Chen I; Safe S; Bjeldanes L Biochem Pharmacol; 1996 Apr; 51(8):1069-76. PubMed ID: 8866829 [TBL] [Abstract][Full Text] [Related]
80. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line. de Waard PW; de Kok TM; Maas LM; Peijnenburg AA; Hoogenboom RL; Aarts JM; van Schooten FJ Mutagenesis; 2008 Jan; 23(1):67-73. PubMed ID: 18065724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]